Skip to main content
Nautilus Biotechnology, Inc. logo

Nautilus Biotechnology, Inc. — Investor Relations & Filings

Ticker · NAUT ISIN · US63909J1088 US Professional, scientific and technical activities
Open in API
Filings indexed 299 across all filing types
Latest filing 2021-08-10 Interim / Quarterly Rep…
Country US United States of America
Listing US NAUT

About Nautilus Biotechnology, Inc.

https://www.nautilus.bio/

Nautilus Biotechnology, Inc. is a life sciences company developing a platform to revolutionize proteome analysis. The company's Proteome Analysis Platform is designed to quantify proteins at the single-molecule level, leveraging a proprietary method called Iterative Mapping. This technology aims to provide high-resolution views of billions of individual protein molecules and their modifications (proteoforms). The platform is being developed with two key modalities: broadscale proteomic analysis for comprehensive proteome exploration and targeted proteoform analysis for in-depth examination of protein variants. The intended applications include accelerating drug target identification, discovering more effective biomarkers, and enabling foundational biological research by making advanced proteomics more accessible to the scientific community.

Recent filings

Filing Released Lang Actions
10-Q
Interim / Quarterly Report Q2 2021
2021-08-10 English
8-K
Earnings Release Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated August 10, 2021, by Nautilus Biotechnology, Inc. It specifically states in Item 2.02 that the company issued a press release reporting its financial results for the quarter ended June 30, 2021. The document includes the press release as an exhibit but does not contain the full financial statements or detailed financial analysis itself. The length of the document is 3454 characters, which is relatively short and consistent with a current report or announcement rather than a full interim or annual report. The document is primarily an announcement of quarterly financial results via a press release, which aligns with the definition of an Earnings Release (ER). Therefore, the appropriate classification is Earnings Release (ER).
2021-08-09 English
Regulatory Filings 2021
Regulatory Filings
2021-08-09 English
424B3
Capital/Financing Update Classification · 95% confidence The document is a prospectus filed pursuant to Rule 424(b)(3) under a Registration Statement No. 333-258100. It details the resale of shares of common stock by selling securityholders, including shares issued in connection with a domestication, business combination, and PIPE financing. The document includes sections typical of a prospectus such as Risk Factors, Use of Proceeds, Management's Discussion and Analysis, Business, Management, Executive Compensation, and Legal Matters. It is clearly a registration and offering document related to capital raising and resale of securities. This matches the definition of a Capital/Financing Update (CAP) filing, which covers updates on company fundraising, financing activities, or capital structure changes. The document is not an annual or quarterly report, audit report, or earnings release, nor is it a proxy, voting result, or merger filing. Therefore, the correct classification is CAP with high confidence.
2021-08-06 English
FORM 4
Director's Dealing
2021-08-04 English
Regulatory Filings 2021
Regulatory Filings Classification · 95% confidence The document is a letter addressed to the U.S. Securities and Exchange Commission requesting acceleration of effectiveness for a Registration Statement on Form S-1. It references Rule 461 under the Securities Act of 1933 and is signed by the CEO. The content is a formal regulatory communication related to a securities registration process, not a financial report or detailed filing itself. The document length is short (1583 characters), and it is clearly an official regulatory filing or correspondence rather than a report or announcement of financial results. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for such regulatory communications that do not fit other specific categories.
2021-08-03 English

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.